Related Experiment Video

Updated: Jun 8, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Gene therapy for liver cancer: clinical experience and future prospects

Bruno Sangro1, Jesus Prieto

  • 1Clinica Universitaria de Navarra, Liver Unit, Avenida Pio XII 36, 31008 Pamplona, Spain. bsangro@unav.es

Current Opinion in Molecular Therapeutics
|October 2, 2010
PubMed

Insights

Gene therapy for liver cancer shows promise but faces challenges. While safe and demonstrating tumor cell killing, limited efficacy in clinical trials necessitates improved delivery and vector technology for future success.

Area of Science:

  • Oncology
  • Gene Therapy
  • Hepatology

Background:

  • Preclinical studies show gene therapy efficacy for liver cancer, yet clinical translation remains limited.
  • Few gene therapy agents have advanced to clinical trials for primary and secondary liver cancer treatment.

Purpose of the Study:

  • To review clinical trials on gene therapy for liver cancer, assessing feasibility, safety, and efficacy.
  • To identify challenges and potential improvements for gene therapy in liver cancer treatment.

Main Methods:

  • Review of published clinical trials exploring various gene therapy strategies.
  • Analysis of safety, transgene expression, and efficacy data from these trials.

Main Results:

  • Gene therapy for liver cancer has been demonstrated as safe, with no agents reaching maximum tolerated dose (MTD).
  • While phase II trials showed limited significant response rates, objective remissions and proof-of-concept for tumor cell killing were observed.
  • Transgene expression was detected, but insufficient delivery and short expression duration were noted.

Conclusions:

  • Gene therapy is safe for liver cancer treatment, with established proof-of-concept for tumor cell killing.
  • Limited antitumor efficacy is attributed to delivery issues and transient transgene expression.
  • Development of advanced gene therapy vectors is crucial for enhancing treatment success in liver cancer.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...